Natera, Inc. (NTRA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
108.65+1.33 (+1.24%)
As of 9:39AM EDT. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 107.32 |
| Open | 108.53 |
| Bid | 90.00 x 900 |
| Ask | 110.00 x 1000 |
| Day's Range | 108.34 - 109.98 |
| 52 Week Range | 30.17 - 127.19 |
| Volume | 26,918 |
| Avg. Volume | 871,759 |
| Market Cap | 9.406B |
| Beta (5Y Monthly) | 1.31 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.84 |
| Earnings Date | Feb 25, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 137.11 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- PR Newswire
Natera Implements First Wave of Panorama® AI Improvements With Immediate Impact on Patient Experience and COGS
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, has implemented the first wave of Panorama AI innovations following the breakthrough results shared earlier from the SMART study.
- Motley Fool
3 Cancer Diagnostic Monster Stocks on Sale
These under-the-radar stocks have had incredible growth over the last 5 years, and are all off over 15% from their highs.
- PR Newswire
Natera and Tesis Labs Announce Strategic Collaboration on Prenatal Genetic Testing
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in non-invasive genetic testing and analysis of cfDNA, and Tesis Labs, a US multi-region lab services provider with labs in Colorado, Texas and Arizona, announced a strategic partnership in the field of prenatal genetic testing.
© 2021 Verizon Media. All rights reserved.
